Medtronic Expands Recall of MiniMed 600 Series Insulin Pumps

Medtronic Expands Recall of MiniMed 600 Series Insulin Pumps
  • The FDA has announced that Medtronic Plc MDT has expanded the Class I recall of its MiniMed 600 series insulin pumps.
  • Medtronic is offering to replace all MiniMed 600 series insulin pumps that have a clear retainer ring. The retainer ring helps to lock the insulin cartridge into place in the pump's reservoir compartment. 
  • If the cartridge is not locked firmly into place, under or over insulin delivery may occur.
  • In a separate update, FDA said Medtronic expanded an August 2018 recall of remote controllers used with the MiniMed 508 and Paradigm family of insulin pumps due to cybersecurity risks. 
  • FDA said it was unaware of any reports of harm to patients related to the cybersecurity problem.
  • The FDA said that Medtronic is recalling 31,310 devices because an unauthorized person could record the wireless communication between the remote and insulin pump. 
  • Patients who have not programmed a remote controller ID into the pump or selected the related bolus option are not affected.
  • Related: Medtronic Pulls Plug On Heart Implant Device Amid Growing Concerns Over Patient Safety.
  • Price Action: MDT stock is down 0.20% at $125.55 during the market session on the last check Wednesday.

Posted In: BriefsrecallNewsHealth CareFDAGeneral